Generic pharmaceuticals

/Tag: Generic pharmaceuticals

Foul play with generic drugs threatens American lives

This is becoming the year of the health care “hot potato,” as various players in the market battle over who is the villain. The Senate Finance Committee kicked off 2019 with hearings aimed at getting to the root of soaring prescription drug prices and identifying bad actors. Suggested solutions ranged from banning price spreading to reforming rebate programs. Yet

Intermountain to fight pharmaceutical monopolies

As Dan Liljenquist watched former Turing Pharmaceuticals CEO Martin Shkreli raise a rarely-heard-of-drug more than 550%, he had the same thought as nearly everyone else in America: Is this really happening? But unlike most Americans, Liljenquist happens to be in a position to do something about it. The former Utah state senator and the vice president of

The story of Alvogen and the founding of a pharma empire

The pharmaceutical sector in the United States is undergoing a seismic shift. In recent years, generic pharmaceuticals, which are equivalent to branded drugs in everything apart from their price and name, have been expanding their share of the market at a rapid pace. At around 50 to 70 percent cheaper than their branded equivalents, more

Curing America’s Expensive Drugs

The United States spent $457 billion on prescription drugs in 2015, nearly 17 percent of total healthcare spending. The Department of Health and Human Services estimates this figure will grow to $535 billion by 2018. Bringing a new drug to the market is notoriously expensive due to research and development, time opportunity costs, and jumping through hoops for FDA